Recent Research Explores the Global Equine Pharmaceuticals and Supplements Market 2023

 Marketresearchdata Marketresearchdata
  14th-Nov-2017
 589

Type or Copy and Paste YoInfinium Global Research has added a new report on Global Equine Pharmaceuticals and Supplements Market. The report predicts the market size of Equine Pharmaceuticals and Supplements is expected to reach XX billion by 2023.

The global equine pharmaceuticals and supplements market is projected to reach USD X.xx billion by 2023, growing with a CAGR of 2.0 % to 2.5% from 2017 to 2023. Governments and various animal health institutions spread awareness about the need for good healthy diets and health supplements for the growth and healthy life of the horses among the horse breeders and trainers in various equine industries. Moreover, they provide information and awareness about the need for prevention of certain diseases and the remedy for some medical conditions. Increasing awareness about equine pharmaceuticals and supplements products is driving the growth of the global equine pharmaceuticals and supplements market. Demand for herbal digestive, feed, and energy supplements for horses are increasing due to the preference among horse breeders and trainers for natural products and it is expected to drive the growth of the pharmaceuticals and supplements market. The horseracing and equestrian sectors drive the demand for equine pharmaceutical products, as the health of the horses are very important for sustaining the growth of those sectors. Healthy horses in these sectors provide the impetus for the betting and gambling industries related to horse racing. Therefore, most of the trainers and breeders of horses adopt advanced pharmaceutical products for preventing illnesses and for healing the diseases, so that the horses are in good shape for the races.

Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/54

Segments Covered:

The report segments the global equine pharmaceuticals and supplements market by product type, distribution channels and region. On the basis of product, the market is segmented as pharmaceuticals and supplements. Based on distribution channel, the market is segmented as veterinary hospitals, drugstores, and some others.

Companies Profiled:

Affymetrix,

Bayer Animal Health,

Boehringer Ingelheim,

Celltrion Inc,

Elanco Animal Health,

Merck Animal Health,

Merial,

Novartis Animal Health,

Vetoquinol and Zoetis.

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/54

Key topics covered:

1. Preface

2. Executive Summary

3. Global Insulation Materials Market Overview

4. Global Equine Pharmaceuticals and Supplements Market Analysis, by Product 2017 – 2023

5. Global Equine Pharmaceuticals and Supplements Market Analysis, by Distribution Channel 2017 – 2023

6. Global Equine Pharmaceuticals and Supplements Market Analysis, by Region 2017 – 2023

7. Company Profiles

Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/equine_pharmaceuticals_supplements_marketur text here, Only 30,000 characters are allowed

Domain: Business
Category: Sales & Marketing
Contributing Organization:
Contact Person Address: sale@infiniumglobalresearch.com
Posted By: Marketresearchdata Marketresearchdata and Contact Marketresearchdata Marketresearchdata

Recent Press Releases

Digital Banking Platform Market: Dev...

Digital banking platform is a multichannel solution of personal banking services. A digitally advanced platform for banking integrates with hundreds of banking endpoints covering d

22 February, 2019

AWS Managed Services Market: Project...

AWS Managed Services is a suite of services and tools that automate the basic management of tasks for Amazon Web Services (AWS) applications. The goal of this service is addressed

22 February, 2019

Global Healthcare IT Market Professi...

A new study added recently to the repository of QY Reports offers a comprehensive overview of the global market for Healthcare IT The Market study namely “Global Healthcare I

22 February, 2019